A detailed history of Squarepoint Ops LLC transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 12,385 shares of TARA stock, worth $68,241. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,385
Previous 24,374 49.19%
Holding current value
$68,241
Previous $73,000 27.4%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$2.78 - $4.41 $33,329 - $52,871
-11,989 Reduced 49.19%
12,385 $53,000
Q2 2025

Aug 27, 2025

BUY
$2.88 - $4.42 $34,968 - $53,667
12,142 Added 99.26%
24,374 $73,000
Q2 2025

Aug 14, 2025

BUY
$2.88 - $4.42 $34,968 - $53,667
12,142 Added 99.26%
24,374 $73,000
Q1 2025

Aug 27, 2025

SELL
$3.37 - $6.14 $40,918 - $74,551
-12,142 Reduced 49.82%
12,232 $52,000
Q1 2025

May 15, 2025

SELL
$3.37 - $6.14 $28,722 - $52,331
-8,523 Reduced 41.06%
12,232 $52,000
Q4 2024

Feb 14, 2025

BUY
$1.68 - $7.53 $34,868 - $156,285
20,755 New
20,755 $108,000

Others Institutions Holding TARA

About Protara Therapeutics, Inc.


  • Ticker TARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,267,400
  • Market Cap $62.1M
  • Description
  • Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...
More about TARA
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.